(Q38266745)

1 September 2017

1 reference

title

Paraganglioma and phaeochromocytoma: from genetics to personalized medicine (English)

1 reference

Anne-Paule Gimenez-Roqueplo

1 September 2017

main subject

personalized medicine

1 reference

1 reference

Judith Favier

1

0 references

Laurence Amar

object named as

Laurence Amar

series ordinal

2

0 references

object named as

Anne-Paule Gimenez-Roqueplo

series ordinal

3

0 references

publication date

11 November 2014

1 reference

Nature Reviews Endocrinology

1 September 2017

published in

1 reference

1 September 2017

volume

11

1 reference

1 September 2017

issue

2

1 reference

1 September 2017

page(s)

101-111

1 reference

https://scigraph.springernature.com/pub.10.1038/nrendo.2014.188

1 September 2017

exact match

0 references

cites work

Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.188

Germline SDHD mutation in familial phaeochromocytoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.188

Pheochromocytoma--death of an axiom

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.188

Pheochromocytoma: recommendations for clinical practice from the First International Symposium. October 2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.188

Pheochromocytoma and paraganglioma pathogenesis: learning from genetic heterogeneity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.188

A decade (2001-2010) of genetic testing for pheochromocytoma and paraganglioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.188

Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.188

Comprehensive mutation scanning of NF1 in apparently sporadic cases of pheochromocytoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.188

Health supervision for children with neurofibromatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.188

Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.188

Guidelines for diagnosis and therapy of MEN type 1 and type 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.188

Medullary thyroid cancer: management guidelines of the American Thyroid Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.188

Identification of the von Hippel-Lindau disease tumor suppressor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.188

von Hippel-Lindau disease: a clinical and scientific review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.188

Germline mutations in FH confer predisposition to malignant pheochromocytomas and paragangliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.188

Genetic testing in pheochromocytoma or functional paraganglioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.188

Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.188

Mutations in SDHC cause autosomal dominant paraganglioma, type 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.188

SDHA is a tumor suppressor gene causing paraganglioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.188

Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.188

SDH5, a gene required for flavination of succinate dehydrogenase, is mutated in paraganglioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.188

Accumulation of Krebs cycle intermediates and over-expression of HIF1alpha in tumours which result from germline FH and SDH mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.188

Mitochondrial succinate is instrumental for HIF1alpha nuclear translocation in SDHA-mutant fibroblasts under normoxic conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.188

SDH mutations establish a hypermethylator phenotype in paraganglioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.188

Mitochondrial complex II and genomic imprinting in inheritance of paraganglioma tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.188

SDH mutations in tumorigenesis and inherited endocrine tumours: lesson from the phaeochromocytoma-paraganglioma syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.188

The clinical phenotype of SDHC-associated hereditary paraganglioma syndrome (PGL3).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.188

Germline SDHB mutations and familial renal cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.188

Clinical and molecular genetics of patients with the Carney-Stratakis syndrome and germline mutations of the genes coding for the succinate dehydrogenase subunits SDHB, SDHC, and SDHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.188

Germline mutations in TMEM127 confer susceptibility to pheochromocytoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.188

Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.188

The tumor susceptibility gene TMEM127 is mutated in renal cell carcinomas and modulates endolysosomal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.188

MAX and MYC: a heritable breakup

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.188

MAX Mutations Cause Hereditary and Sporadic Pheochromocytoma and Paraganglioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.188

Somatic HIF2A gain-of-function mutations in paraganglioma with polycythemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.188

Mosaicism in HIF2A-related polycythemia-paraganglioma syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.188

The kinesin KIF1Bbeta acts downstream from EglN3 to induce apoptosis and is a potential 1p36 tumor suppressor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.188

Distinct deregulation of the hypoxia inducible factor by PHD2 mutants identified in germline DNA of patients with polycythemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.188

Isocitrate dehydrogenase mutations are rare in pheochromocytomas and paragangliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.188

Somatic mutations in H-RAS in sporadic pheochromocytoma and paraganglioma identified by exome sequencing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.188

H-RAS mutations are restricted to sporadic pheochromocytomas lacking specific clinical or pathological features: data from a multi-institutional series.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.188

Risk of malignant paraganglioma in SDHB-mutation and SDHD-mutation carriers: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.188

Metastatic pheochromocytoma/paraganglioma related to primary tumor development in childhood or adolescence: significant link to SDHB mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.188

Biochemical diagnosis of pheochromocytoma: which test is best?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.188

An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.188

Aberrant succination of proteins in fumarate hydratase-deficient mice and HLRCC patients is a robust biomarker of mutation status

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.188

Next-generation sequencing in the clinical genetic screening of patients with pheochromocytoma and paraganglioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.188

Rare germline mutations identified by targeted next-generation sequencing of susceptibility genes in pheochromocytoma and paraganglioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.188

Guidelines for investigating causality of sequence variants in human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.188

Pitfalls in genetic analysis of pheochromocytomas/paragangliomas-case report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.188

Imaging work-up for screening of paraganglioma and pheochromocytoma in SDHx mutation carriers: a multicenter prospective study from the PGL.EVA Investigators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.188

EANM 2012 guidelines for radionuclide imaging of phaeochromocytoma and paraganglioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.188

Comparison of 18F-fluoro-L-DOPA, 18F-fluoro-deoxyglucose, and 18F-fluorodopamine PET and 123I-MIBG scintigraphy in the localization of pheochromocytoma and paraganglioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.188

Long-term outcomes of surgical treatment for hereditary pheochromocytoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.188

Prognostic factors of disease-free survival after thyroidectomy in 170 young patients with a RET germline mutation: a multicenter study of the Groupe Francais d'Etude des Tumeurs Endocrines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.188

The characterization of pheochromocytoma and its impact on overall survival in multiple endocrine neoplasia type 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.188

Role of rapid sequence whole-body MRI screening in SDH-associated hereditary paraganglioma families.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.188

Staging and functional characterization of pheochromocytoma and paraganglioma by 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.188

Distinct gene expression profiles in norepinephrine- and epinephrine-producing hereditary and sporadic pheochromocytomas: activation of hypoxia-driven angiogenic pathways in von Hippel-Lindau syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.188

A HIF1alpha regulatory loop links hypoxia and mitochondrial signals in pheochromocytomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.188

The Warburg effect is genetically determined in inherited pheochromocytomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.188

Research resource: Transcriptional profiling reveals different pseudohypoxic signatures in SDHB and VHL-related pheochromocytomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.188

Integrative genomics reveals frequent somatic NF1 mutations in sporadic pheochromocytomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.188

Rationale and evidence for sunitinib in the treatment of malignant paraganglioma/pheochromocytoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.188

Use of the tyrosine kinase inhibitor sunitinib in a patient with von Hippel-Lindau disease: targeting angiogenic factors in pheochromocytoma and other von Hippel-Lindau disease-related tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.188

Patient with malignant paraganglioma responding to the multikinase inhibitor sunitinib malate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.188

Treatment with sunitinib for patients with progressive metastatic pheochromocytomas and sympathetic paragangliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.188

Modes of resistance to anti-angiogenic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.188

Novel and evolving therapies in the treatment of malignant phaeochromocytoma: experience with the mTOR inhibitor everolimus (RAD001).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.188

Phase 2 study of everolimus monotherapy in patients with nonfunctioning neuroendocrine tumors or pheochromocytomas/paragangliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.188

Combined inhibition of mTORC1 and mTORC2 signaling pathways is a promising therapeutic option in inhibiting pheochromocytoma tumor growth: in vitro and in vivo studies in female athymic nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.188

Succinate dehydrogenase mutation underlies global epigenomic divergence in gastrointestinal stromal tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.188

Epithelial to mesenchymal transition is activated in metastatic pheochromocytomas and paragangliomas caused by SDHB gene mutations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.188

Supplemental ascorbate in the supportive treatment of cancer: Reevaluation of prolongation of survival times in terminal human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.188

Whole exome sequencing is an efficient and sensitive method for detection of germline mutations in patients with phaeochromcytomas and paragangliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.188

SDHBmutations are associated with response to temozolomide in patients with metastatic pheochromocytoma or paraganglioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.188

Somatic NF1 inactivation is a frequent event in sporadic pheochromocytoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.188

Succinate Dehydrogenase B Gene Mutations Predict Survival in Patients with Malignant Pheochromocytomas or Paragangliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.188

The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.188

Clinical and genetic characteristics of patients with neurofibromatosis type 1 and pheochromocytoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.188

Loss of expression of SDHA predicts SDHA mutations in gastrointestinal stromal tumors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.188

TMEM127 screening in a large cohort of patients with pheochromocytoma and/or paraganglioma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.188

SDHA Immunohistochemistry Detects GermlineSDHAGene Mutations in Apparently Sporadic Paragangliomas and Pheochromocytomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.188

The role of 6-[18F]fluorodopamine positron emission tomography in the localization of adrenal pheochromocytoma associated with von Hippel-Lindau syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.188

[Adrenalectomy for preservation of adrenocortical function. Indication and results]

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.188

Minimally invasive cortical-sparing surgery for bilateral pheochromocytomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.188

Phenotypic variability and risk of malignancy in SDHC-linked paragangliomas: lessons from three unrelated cases with an identical germline mutation (p.Arg133*)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.188

HIF2AMutations in Paraganglioma with Polycythemia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.188

Analysis of plasma 3-methoxytyramine, normetanephrine and metanephrine by ultraperformance liquid chromatography-tandem mass spectrometry: utility for diagnosis of dopamine-producing metastatic phaeochromocytoma

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25385035

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Mutations in the SDHB gene are associated with extra-adrenal and/or malignant phaeochromocytomas.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25385035

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

von Recklinghausen's disease and pheochromocytomas

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25385035

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/NRENDO.2014.188

1 reference

Dimensions Publication ID

1 September 2017

1038509181

0 references

1 reference